GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase  by Munn, David H. et al.
Immunity, Vol. 22, 633–642, May, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.immuni.2005.03.013
GCN2 Kinase in T Cells
Mediates Proliferative Arrest and Anergy Induction
in Response to Indoleamine 2,3-Dioxygenase
David H. Munn,1,2,* Madhav D. Sharma,1,2
Babak Baban,2 Heather P. Harding,3 Yuhong Zhang,3
David Ron,3 and Andrew L. Mellor2,4
1Department of Pediatrics
2 Institute for Molecular Medicine and Genetics
Medical College of Georgia
Augusta, Georgia 30912
3The Skirball Institute
New York University School of Medicine
New York, New York 10016
4Department of Medicine
Medical College of Georgia
Augusta, Georgia 30912
Summary
Indoleamine 2,3 dioxygenase (IDO) catabolizes the
amino acid tryptophan. IDO-expressing immunoregu-
latory dendritic cells (DCs) have been implicated in
settings including tumors, autoimmunity, and trans-
plant tolerance. However, the downstream molecular
mechanisms by which IDO functions to regulate T cell
responses remain unknown. We now show that IDO-
expressing plasmacytoid DCs activate the GCN2 ki-
nase pathway in responding T cells. GCN2 is a stress-
response kinase that is activated by elevations in
uncharged tRNA. T cells with a targeted disruption of
GCN2 were not susceptible to IDO-mediated sup-
pression of proliferation in vitro. In vivo, proliferation
of GCN2-knockout T cells was not inhibited by IDO-
expressing DCs from tumor-draining lymph nodes.
IDO induced profound anergy in responding wild-type
T cells, but GCN2-knockout cells were refractory to
IDO-induced anergy. We hypothesize that GCN2 acts
as a molecular sensor in T cells, allowing them to de-
tect and respond to conditions created by IDO.
Introduction
Indoleamine 2,3-dioxygenase (IDO) is a potent immu-
noregulatory enzyme. As recently reviewed (Grohmann
et al., 2003; Mellor and Munn, 2004), expression of IDO
allows certain macrophages and dendritic cells (DCs)
to inhibit T cell proliferation in vitro and in vivo. Trans-
fection with IDO confers suppressor activity on tumors
and tumor cell lines, and delays the rejection of grafted
cells and tissues. Endogenous IDO contributes to ma-
ternal tolerance toward the allogeneic fetus, self-toler-
ance in NOD mice, and control of autoimmune enceph-
alitis, experimental asthma, and inflammatory bowel
disease. IDO may also serve as a downstream suppres-
sor mechanisms used by certain Tregs, and by the im-
munosuppressive agent CTLA4-Ig. In tumor-bearing
hosts, IDO-expressing DCs are found in tumor-draining
lymph nodes (TDLNs) of both humans and mice (Munn
et al., 2004a; Munn et al., 2002). The IDO+ plasmacytoid*Correspondence: dmunn@mail.mcg.eduDCs (PDCs) from murine TDLNs actively suppress T cell
proliferation in vitro, and create profound antigen-spe-
cific anergy in vivo (Munn et al., 2004a).
Despite growing recognition of its biologic impor-
tance, the molecular mechanism(s) by which IDO func-
tions to regulate T cell responses remain unclear. Two
hypotheses have been advanced: either that IDO gen-
erates immunosuppressive metabolites of tryptophan
(Grohmann et al., 2003) or that IDO locally depletes
tryptophan to the point that T cells are unable to prolif-
erate (Mellor and Munn, 2004). These are not mutually
exclusive possibilities, and each may play a role in the
biology of IDO. However, it is impossible to directly
measure tryptophan or its metabolites in living cells, so
these hypotheses have remained largely speculative.
To circumvent this impasse, we focused instead on
identifying specific molecular pathways in T cells that
responded to the conditions created by IDO and that
therefore might mediate its downstream effects.
IDO degrades the essential amino acid tryptophan,
so we hypothesized that IDO might affect pathways
known to respond to amino acid metabolism. One pos-
sibility was the nutrient-sensitive mTOR kinase path-
way (Fingar and Blenis, 2004). However, we, like others
(Fox et al., 2005), found that that inhibitors of mTOR
such as rapamycin did not recapitulate the profound
proliferative arrest seen with IDO-mediated suppres-
sion. In yeast, there exists a second amino acid-sensi-
tive pathway which is mediated by the kinase GCN2
(Hinnebusch, 1994). GCN2 contains a regulatory do-
main that binds the uncharged form of transfer RNA
(tRNA). Amino acid insufficiency causes a rise in un-
charged tRNA, which activates the GCN2 kinase do-
main and initiates downstream signaling (Dong et al.,
2000). Recently, the mammalian homolog of GCN2 has
been identified and shown to have similar signaling
properties (Harding et al., 2000a; Sood et al., 2000).
Activation of GCN2 initiates a characteristic stress-
response program conserved from yeast to mammals
(Harding et al., 2003; Natarajan et al., 2001). This path-
way, which has been termed the integrated stress
response (ISR), can trigger cell-cycle arrest, differentia-
tion, compensatory adaptation, or apoptosis, depend-
ing on the cell type and the initiating stress (Crosby et
al., 2000; Harding et al., 2000b; Niwa and Walter, 2000;
Rao et al., 2004). In the current study, we test the hy-
pothesis that expression of IDO by APCs activates the
GCN2 kinase pathway in responding T cells, generating
an intracellular signal that mediates key biologic effects
of IDO.
Results
Tryptophan Supplementation Reverses
IDO-Mediated Suppression
We first asked whether tryptophan supplementation
could prevent IDO-mediated suppression during mixed
leukocyte reactions (MLRs). IDO+ PDCs (B220+CD11c+)
were isolated from murine TDLNs (Munn et al., 2004a).
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tResponder cells in MLRs were purified CD8+ TCR-
transgenic T cells: either OT-I (recognizing an oval- d
tbumin peptide) or BM3 (recognizing H2Kb as an alloan-
tigen). Figure 1A shows that TDLN PDCs effectively (
Gsuppressed proliferation of OT-I cells, and this was ab-
rogated by supplementation excess L-tryptophan (10× t
Cthe normal concentration in RPMI medium) or by block-
ing IDO activity with the pharmacologic inhibitor i
s1-methyl-D-tryptophan (1MT). In contrast, MLRs stim-
ulated by conventional DCs (CD11c+B220NEG) from the T
usame LNs showed no suppression, and neither 1MT nor
10× tryptophan had any effect on proliferation. G
PThe absence of T cell proliferation was not due to a
failure of the PDCs to present antigen, since (as showna
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Figure 1. Exogenous Tryptophan Prevents IDO-Mediated Sup- p
pression i
(A) IDO+ PDCs (CD11c+B220+) or nonsuppressive conventional DCs v
(CD11c+B220NEG) were isolated from TDLNs, and used to present s
cognate SIINFEKL peptide to OT-I T cells in MLRs. Cultures re-
rceived 250 M tryptophan (10× TRP), 200 M 1MT, or no additive.
TThe arrow indicates the component of IDO-mediated suppression
(*p < .01 by ANOVA, compared to all other groups). (
(B) Dominant suppression is blocked by 10× tryptophan. TDLN m
PDCs derived from IDO-sufficient hosts (left panel) mediated domi- s
nant suppression when added to MLRs stimulated by nonsuppres- C
sive APCs from the same LN (“Control MLR”, BM3 responders). In
tcontrast, TDLN PDCs from IDO-knockout hosts (right panel)
oshowed no suppression (*p < .01 by ANOVA).
(C) Polyclonal CD4+ T cells contain a nonspecific suppressor activ- c
ity, unrelated to IDO. (Left panel) Comparison of sorted CD8+ versus s
CD4+ polyclonal T cell responders, using TDLN PDCs plus anti- s
CD3 mitogen as stimulators (*p < .01 by ANOVA versus the two s
other CD8 groups; **p < .01 versus the CD8 groups). (Right panel)
Naive TCR-transgenic CD4+ T cell responders from female A1 mice,
with cognate HY peptide presented by either IDO-expressing C
B220+ PDCs versus nonsuppressive B220NEG conventional DCs, T
both from TDLNs (*p < .01 by ANOVA versus the two other groups). above) the PDCs were excellent APCs as long as IDO
as blocked. Rather, the IDO+ PDCs appeared to be
ctively and dominantly suppressive, as shown in Fig-
re 1B. IDO+ PDCs were mixed with an excess of non-
uppressive (CD11c+B220NEG) DCs, and the mixed
opulation used as stimulators for BM3 T cells. The
arget H2Kb alloantigen was constitutively expressed at
igh levels on both populations of DCs, so effective an-
igen presentation was assured. Despite this, the IDO+
DCs dominantly suppressed all T cell proliferation in
he mixed cultures. This occurred in an IDO-dependent
ashion, since suppression was reversed by 10× trypto-
han and 1MT, and TDLN PDCs derived from mice with
targeted disruption of the IDO gene (IDO-KO mice,
ight panel) showed no suppression.
The preceding studies focused on TCR-transgenic
D8+ responder cells. Nontransgenic (polyclonal) CD8+
cells showed a similar pattern IDO-mediated sup-
ression (Figure 1C, left panel). However, as shown in
he same panel, polyclonal CD4+ T cells displayed a
igh level of nonspecific regulatory/suppressor activity,
hich inhibited essentially all proliferative responses.
his was not IDO-mediated (since it was not reversed
y 1MT or 10× tryptophan), and it was observed only
hen PDCs from TDLNs were used as APCs for poly-
lonal CD4+ T cells. (In other experiments, data not
hown, conventional B220NEG DCs stimulated normal
roliferation of CD4+ cells.) Thus, the nonspecific sup-
ression appeared to represent a Treg-like activity, sim-
lar to the potent CD4+ Treg activity that we have pre-
iously described in TDLNs (Munn et al., 2004a). This
uppressor activity was present in the polyclonal CD4+
epertoire, but it was not an intrinsic feature of all CD4+
cells, because naive TCR-transgenic CD4+ T cells
recognizing a male HY peptide, and taken from female
ice so as to be obligately naive) displayed no such
uppressor activity (Figure 1C, right panel). These naive
D4+ T cells responded to IDO-expressing PDCs iden-
ically to CD8+ T cells. However, because the presence
f nonspecific suppressor activity potentially compli-
ated the interpretation of results using CD4+ cells, in
ubsequent experiments we used purified CD8+ re-
ponder cells. This allowed us to unambiguously as-
ess the specific effects of IDO.
HOP Is a Marker for GCN2 Activation in T Cells
here is no technique to directly measure the kinase
ctivity of GCN2 in intact cells. Therefore, in order to
sk whether IDO activated GCN2 in T cells, we wished
o identify a downstream marker whose expression was
ependent on GCN2 and that could serve as a “repor-
er” for intracellular GCN2 activation. The CHOP gene
also known as gadd153) is a well-accepted marker for
CN2 activation, and CHOP protein can be readily de-
ected by specific antisera (Harding et al., 2000a). While
HOP can be induced by other stresses as well, its
nduction by amino acid deprivation is known to be
pecifically mediated by GCN2 (Harding et al., 2000a).
o define the mechanistic role of GCN2 in T cells, we
sed mice homozygous for a targeted deletion in the
CN2 locus (GCN2-KO), as described in Experimental
rocedures.
Spleen cells were isolated from GCN2-KO mice or
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635wild-type controls, then cultured in tryptophan-free me-
dium for 24 hr and tested for CHOP induction. Controls
received graded amounts of added tryptophan. All
groups were activated either with phorbol myristate ac-
etate (PMA) and ionomycin, or with TCR cross linking
(anti-CD3 antibody), both of which gave identical re-
sults. Figure 2A shows that activated wild-type T cells
upregulated CHOP when the concentration of trypto-
phan fell below w3 M, whereas GCN2-deficient T
cells showed no expression of CHOP. CHOP induction
occurred only if the T cells were activated, either by
anti-CD3/CD28 crosslinking, or by PMA+ionomycin
(Figure 2B). This requirement for both T cell activation
and tryptophan withdrawal was also seen at the level
of CHOP mRNA (Figure 2C). In all cases, CHOP induc-
tion was strictly dependent on an intact GCN2 pathway.
Thus, we concluded that CHOP expression served as
an informative downstream marker of GCN2 activity in
activated T cells.Figure 2. GCN2-Mediated Upregulation of CHOP in T Cells
(A) GCN2-dependent upregulation of CHOP in tryptophan-deficient
medium. Splenocytes cultured in chemically defined medium with
graded amounts of tryptophan. Cells were activated for 24 hr using
either PMA + ionomycin (shown) or immobilized anti-CD3 + anti-
CD28 antibodies (which gave similar results). CHOP expression
was analyzed by western blot. Experiments were performed on
wild-type cells (upper blot) or GCN2-KO cells (lower blot). Mem-
branes were stripped and reblotted for β-actin as a loading control.
One of two identical experiments.
(B) CHOP upregulation requires simultaneous T cell activation and
tryptophan withdrawal. Splenic T cells from wild-type or GCN2-KO
mice were cultured with or without activation (PMA+ionomycin) in
the presence or absence of tryptophan (25 M). CHOP was mea-
sured by western blot after 24 hr with β-actin as a loading control.
One of three experiments.
(C) CHOP is induced at the mRNA level by tryptophan withdrawal.
Experiments were performed as in the previous panel, and CHOP-
specific mRNA measured by quantitative real-time RT-PCR. Data
are normalized to γ-actin expression in each sample. One of five ex-
periments.GCN2 Is Activated by IDO
To ask whether GCN2 was activated when T cells were
exposed to IDO, we examined intracellular CHOP in-
duction in T cells during MLRs. Polyclonal CD8+ T cells
were isolated from wild-type or GCN2-KO mice, mixed
with IDO+ PDCs from TDLNs, and activated with anti-
CD3 mitogen. CHOP was assessed by intracellular im-
munofluorescent staining and flow cytometry. Experi-
ments were performed with and without 1MT to block
IDO activity. Figure 3A shows that the majority of wild-
type T cells had upregulated CHOP after 24 hr in MLRs.
CHOP induction was IDO dependent, since T cells
showed no CHOP expression when IDO activity was
inhibited by 1MT (identical results were obtained using
PDCs from IDO-knockout mice, data not shown). CHOPFigure 3. GCN2 Is Required for Suppression of T Cells by IDO-
Expressing PDCs
(A) Upregulation of CHOP by IDO during MLRs. Sorted polyclonal
CD8+ T cells from wild-type mice (upper panel) or GCN2-KO mice
(lower panel) were activated in MLRs with IDO+ TDLN PDCs, using
anti-CD3 mitogen. MLRs were performed without 1MT (black line)
or with 1MT (grey line). After 24 hr, intracellular CHOP expression
was measured by FACS. Histograms show CHOP staining in the
gated CD8+ T cell population in each MLR. Vertical bars show the 2
SD cutoff for each isotype-matched negative control. (The negative
control histograms are omitted for clarity, but were identical to the
“(+)1MT” histograms). One of three experiments.
(B) GCN2-KO T cells are resistant to suppression by IDO. Sorted
CD8+ T cells were isolated from either wild-type or GCN2-KO
spleens as shown. TDLN PDCs (CD11c+B220+) were added and
MLRs stimulated by anti-CD3 mitogen, with or without 1MT or 10×
tryptophan. (*p < .01 by ANOVA versus the other wild-type groups.)
(C) Sorted CD8+ T cells were labeled with CFSE, used as respond-
ers in anti-CD3 mitogen assays with TDLN PDCs. Wild-type or
GCN2-KO cells were tested with or without 1MT, as indicated. After
48 hr, cells were analyzed for cell division by CFSE dye dilution.
The marker identifies the nondividing peak in each histogram. One
of three experiments.
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636induction was also strictly GCN2 dependent, since
GCN2-KO T cells showed no CHOP expression under
any conditions (Figure 3A, lower panel).
GCN2-KO T Cells Are Not Suppressed
by IDO+ PDCs
We next asked whether GCN2 was required in order for
T cell proliferation to be suppressed by IDO. Sorted
CD8+ T cells from wild-type or GCN2-KO mice were
used as responders in MLRs. Figure 3B shows that
TDLN PDCs potently suppressed proliferation of wild-
type T cells, whereas GCN2-KO T cells proliferated nor-
mally in the presence of the same PDCs, and showed
no effect of 10× tryptophan or 1MT. Identical results
were also seen in an allogeneic-MLR model (data not
shown) using PDCs from F1(CBA×B6) tumor-bearing
mice and allogeneic T cells from 129 background re-
sponders (wild-type and GCN2-KO). Figure 3C shows
CFSE dye-dilution studies, confirming that GCN2-KO T
cells proliferated normally in the presence of IDO+
PDCs. In all of the preceding experiments, the IDO+
PDCs were derived from GCN2-sufficient (wild-type)
mice, so the role for GCN2 was played out specifically
in the responding T cells.
GCN2 Activates a Selective and Specific
Regulatory Pathway
Like other eIF2α kinases, GCN2 activates the ISR path-
F
way. In principle, this pathway is able to selectively
N
modulate the expression of specific target genes (Har- w
ding et al., 2003). However, no such studies had been h
performed in T cells. We used microarrays to analyze o
pexpression of >34,000 full-length mouse genes before
tand after activation of GCN2. T cells were stimulated
sfor 40 hr with PMA+ionomycin, then treated for 3 hr
p
with 0.25 mM tryptophanol. Tryptophanol is a competi- s
tive inhibitor of the tryptophanyl-tRNA synthetase en-
zyme; by raising the pool of uncharged tRNATRP it acts
as a pharmacologic activator of GCN2 (Jiang et al., t
a2003).
Figure 4 summarizes the results of a representative q
tmicroarray experiment comparing T cells from wild-
type versus GCN2-KO mice, with and without trypto-
phanol. The analysis focuses on transcripts that A
Wchanged R4-fold (up or down) in the wild-type cells
following treatment with tryptophanol (versus control w
mcells receiving buffer only). Of the transcripts showing
a change in the wild-type cells, the GCN2-dependent d
psubset of these was defined as those which failed to
change in GCN2-KO cells (treated identically with tryp- m
Btophanol). Overall, more than 98% of transcripts re-
mained unchanged (<2-fold difference) across all i
Ctreatment groups. Only 0.28% of transcripts in this ex-
periment showed a GCN2-dependent increase at the s
pR4-fold level, and only 0.07% showed a GCN2-depen-
dent decrease. (Changes falling between 2- and 4-fold i
were considered ambiguous, but represented <1% of
total transcripts.) f
oSeveral examples of genes showing GCN2-depen-
dent upregulation are listed in Figure 4. (The few tran- s
(scripts showing GCN2-dependent downregulation were
almost all unknown sequences, and are not listed.) As O
(expected, CHOP was one of the genes upregulated byigure 4. Selective Regulation of Gene Expression by GCN2
ylon wool-enriched T cells (from wild-type or GCN2-KO) mice
ere activated for 40 hr with PMA + ionomycin, then treated for 3
r with 0.25 mM tryptophanol to activate GCN2. (The concentration
f tryptophanol was chosen as the dose that reduced the rate of
roliferation by 50%.) Control cells received buffer alone without
ryptophanol. Microarray hybridization was performed for each
ample, as described in the text. A second, identical experiment
roduced similar results. The examples in the table showed the
ame pattern of changes in both experiments.ryptophanol, and its induction as measured by micro-
rray corresponded closely to the value obtained by
uantitative RT-PCR on the same samples (9-fold for
he experiment shown).
ctivation of the GCN2 Pathway In Vivo
e next asked whether IDO activated the GCN2 path-
ay in vivo. For this we employed two complementary
odels: one in which IDO expression was genetically
efined in the APCs, and a second in which GCN2 ex-
ression was genetically defined in the T cells. The first
odel was a graft-versus-host reaction mediated by
M3 T cells, in which host IDO is known to be strongly
nduced (Munn et al., 1998). Figures 5A–5D show that
HOP was upregulated in a population of cells in
pleen in this model, and that CHOP induction was de-
endent on host IDO (since no cells upregulated CHOP
n IDO-KO hosts).
To ask whether CHOP induction was mediated speci-
ically via GCN2 in responding T cells, we used a model
f genetically defined T cells responding to antigen pre-
ented by adoptively transferred TDLN DCs in vivo
Munn et al., 2004a). Responder T cells were taken from
T-I mice bred onto either the GCN2-KO background
OT-IGCN2-KO) or wild-type background (OT-IWT). Figure
GCN2-Mediated Responses to IDO
637Figure 5. IDO-Induced GCN2-Dependent Upregulation of CHOP
In Vivo
(A–D) IDO-dependent induction of CHOP in vivo. BM3 T cells were
injected into allogeneic F1(CBA×B6) hosts expressing the H2Kb
target antigen. Hosts were either wild-type for IDO, or homozygous
IDO knockout (IDO−/−). After 4 days, spleens were stained for IDO
expression (dark chromogen, panels [A] and [B]) or for CHOP ex-
pression (dark chromogen, panels [C] and [D]). Negative controls
(each primary antibody neutralized with the immunizing peptide)
were comparable to the IDO-KO hosts, and are not shown. (×200).
(E) CD8+ T cells were sorted from OT-I mice bred onto the GCN2-
KO background (OT-IGCN2-KO) or wild-type (OT-IWT). MLRs were
stimulated with IDO+ TDLN PDCs plus SIINFEKL peptide. (*p < .01
by ANOVA versus all other groups.)
(F) Upregulation of CHOP in vivo. CFSE-labeled OT-IWT or
OT-IGCN2-KO cells were transferred into GCN2-KO recipients. DCs
were isolated from TDLNs (sorted CD11c+ cells, as described in
Experimental Procedures) and injected subcutaneously into each
recipient animal. Three days later the draining inguinal LNs were
harvested and stained for intracellular CHOP expression versus
CD8 or CD44. The left-hand dot plot shows expression of CHOP
versus CFSE in the OT-IWT cells. The middle histograms compare
CHOP expression (gated on CFSE+ CD8+ cells) in OT-IWT versus
OT-IGCN2-KO T cells. The right-hand dot plot shows expression of
CHOP versus CD44 in OT-IWT cells (gated on CFSE+). One of three
experiments.5E shows in vitro validation studies using these two cell
types, verifying that OT-IWT T cells were fully sup-
pressed by IDO+ PDCs in MLRs (which was reversedby 1MT and 10× tryptophan), while OT-IGCN2-KO T cells
showed no suppression.
Recipient mice were preloaded with a cohort of
CFSE-labeled OT-IGCN2-KO or OT-IWT responder T cells.
DCs were isolated from TDLNs as described in Experi-
mental Procedures, pulsed with cognate SIINFEKL
peptide, and injected subcutaneously into the pre-
loaded recipients. All recipient mice in these experi-
ments were homozygous GCN2-KO, so that GCN2 ex-
pression would be confined solely to the transferred T
cells; this allowed us to ask if GCN2 expression in the
T cells was both necessary and sufficient for IDO-medi-
ated suppression to occur. Figure 5F shows that a sig-
nificant fraction of the wild-type OT-I cells upregulated
CHOP following exposure to TDLN DCs in vivo. In con-
trast, none of the GCN2-KO T cells expressed CHOP
(middle histograms). Figure 5F further shows that the
population of OT-I cells that became CHOP+ were
specifically those that had encountered antigen (as in-
dicated by upregulation of CD44, a marker for antigen
encounter in OT-I cells [Kurts et al., 1996]). This latter
finding was consistent with the data in Figure 2B, where
we found that CHOP was expressed only when T cells
simultaneously received both a GCN2-activating signal
and a second signal simulating TCR engagement.
Functional Suppression of Wild-Type
OT-I T Cells In Vivo
Figure 6 demonstrates that OT-IWT are functionally sup-
pressed by IDO+ TDLN DC in vivo. Control, nonsup-
pressive DCs (from lymph nodes of normal animals
without tumors) produced a brisk proliferative response
in CFSE-labeled OT-IWT cells (Figure 6A, left panel), and
the proliferating cells upregulated the 1B11 surface an-
tigen (a differentiation marker expressed by activated/
effector CD8+ T cells [Harrington et al., 2000]). In con-
trast, suppressive DCs from TDLNs elicited no prolifer-
ative response from OT-IWT cells, and there was no
upregulation of 1B11 (Figure 6A, right panel). The lack
of response was not due to a failure of the TDLN DCs
to present antigen, since mice receiving TDLN DCs
showed a 6- to 8-fold selective accumulation of OT-IWT
T cells in the LNs draining the site of TDLN DC injection
(Figure 6B, left panel), and the majority of recruited cells
became antigen-experienced (CD44+, Figure 6B, right
panel). Suppression of T cell proliferation was specifi-
cally mediated by IDO, as shown by the fact that ad-
ministration of 1MT to the recipient mice abrogated the
suppressive effect of TDLN DCs, and restored normal
proliferation (Figure 6C).
GCN2 Is Required for Susceptibility
to IDO-Mediated Suppression In Vivo
We next used this model to ask whether GCN2 was
mechanistically required for IDO-mediated suppression
in vivo. Host mice (GCN2-KO) were preloaded with
either OT-IWT or OT-IGCN2-KO T cells, and all mice chal-
lenged with antigen-pulsed TDLN DCs. Figure 7A
shows that both proliferation and upregulation of the
1B11 activation antigen were suppressed in OT-IWT cells
(just as in the preceding figure), whereas OT-IGCN2-KO
T cells proliferated normally, and uniformly upregulated
1B11 expression. Thus, GCN2-deficient T cells dis-
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Figure 6. IDO-Mediated Suppression of Wild-Type OT-I In Vivo p
(A) CFSE-labeled OT-IWT T cells were adoptively transferred into s
wild-type hosts. Mice were injected with either CD11c+ TDLN DCs,
wor normal DCs (from inguinal LNs of animals without tumors). After
3 days, draining LNs were recovered and stained for 1B11 versus
CFSE. The histograms show the fluorescence profiles of the CFSE- D
positive cells, with each 2-fold dilution indicated by a bar. One of
three experiments. I
(B) (Left) Preferential recruitment of OT-IWT T cells into LNs draining
qthe site of TDLN DC injection, compared to contralateral LNs from
tthe same animals. (Right) Expression of CD44 antigen by the CFSE+
nOT-IWT cells in the draining LN. (OT-I cells in the contralateral LNs
showed no CD44 expression, data not shown.) One of three experi- i
ments. e
(C) Abrogation of IDO-mediated suppression by 1MT administra- s
tion in vivo. CFSE-labeled OT-IWT cells were adoptively transferred
mas in the previous panels, and all mice injected with TDLN DCs.
cOne group was treated with 1MT by continuous timed-release pel-
olets, beginning at the time of adoptive transfer. Control mice re-
ceived pellets without 1MT. One of four experiments.
(
kplayed the same indifference to IDO-mediated suppres- t
sion in vivo that they had shown in vitro. a
t
bGCN2 Is Required for IDO-Mediated
Anergy Induction (
mWe have previously shown that IDO-expressing PDCs
induce antigen-specific anergy in responding T cells t
tin vivo (Munn et al., 2004a). Figure 7B shows an in vitrossay demonstrating anergy induction in OT-IWT cells
y IDO. CD8+ T cells from OT-IWT or OT-IGCN2-KO mice
ere activated for 3 days using IDO+ TDLN PDCs. The
uppressed cells (i.e., the OT-IWT cells without 1MT)
ere then harvested, supplemented with fresh medium,
nd restimulated with irradiated B6 splenocytes plus
IINFEKL peptide. Figure 7B (right panel) shows that
uppressed T cells had become completely refractory
o restimulation. This was not due to carryover of the
riginal IDO+ PDCs (most of which did not survive the
nitial MLR and replating step), as shown by the fact
hat 1MT had no ability to restore proliferation in these
econdary MLRs. However, the anergic T cells were
till fully viable, because brisk proliferation could be re-
tored by the addition of exogenous IL-2 to the recall
LR (Figures 7B and 7C). Thus, IDO induced an
nresponsive state consistent with classical anergy
Schwartz, 2003).
One drawback to this in vitro model was that it could
ot directly test whether the GCN2-KO T cells were re-
istant to anergy induction (because, in these experi-
ents, groups that were actively proliferating at the end
f the primary MLR had to be considered “nonanergic”
y definition). We therefore addressed this question
sing the in vivo adoptive-transfer model. CFSE-
abeled OT-IWT or OT-IGCN2-KO T cells were adoptively
ransferred into GCN2-KO hosts and all mice injected
ith peptide-loaded TDLN DCs. After 5 days, CFSE-
abeled CD8+ T cells were recovered from the draining
Ns by FACS sorting and restimulated with irradiated
6 splenocytes plus cognate antigen. Figure 7D shows
hat the OT-IWT T cells had been rendered completely
nergic to restimulation. (Although the OT-IWT cells
ere anergic, they were still present and viable, as
hown by their ability to be rescued by exogenous IL-2.)
n contrast, OT-IGCN2-KO T cells were unaffected by ex-
osure to IDO-expressing DCs and remained fully re-
ponsive in the recall MLRs. Thus, GCN2 expression
as required for IDO-mediated anergy induction in vivo.
iscussion
n the current study, we demonstrate that GCN2 is re-
uired for CD8+ T cells to sense and respond to condi-
ions created by IDO. T cells lacking GCN2 proliferated
ormally in the presence of IDO+ PDCs both in vitro and
n vivo and were not susceptible to IDO-induced an-
rgy. These studies thus identify GCN2 as a down-
tream mediator for several key effects of IDO in our
odels. This constitutes the first elucidation of a spe-
ific molecular target for the immunoregulatory action
f IDO in T cells.
GCN2 is one of a family of four related kinases
GCN2, PERK, HRI, and PKR), which share as their only
nown substrate the alpha subunit of translation initia-
ion factor 2 (eIF2α). Because each of the eIF2α kinases
re activated by different upstream stress signals, yet
arget a similar downstream pathway, this pathway has
een referred to as the integrated stress response (ISR)
Dever, 2002; Harding et al., 2003; Rutkowski and Kauf-
an, 2004). The consequences to the cell of activating
he ISR pathway depend on the nature of the stress,
he specific initiating kinase, and the cell type involved.
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Anergy Induction In Vivo
(A) CFSE-labeled OT-IWT or OT-IGCN2-KO T cells were adoptively
transferred into MHC-matched GCN2-KO hosts. All mice received
TDLN DCs subcutaneously. After 3 days, draining LNs were har-
vested stained for 1B11 versus CFSE. One of four experiments.
(B) Sorted CD8+ T cells from OT-IWT or OT-IGCN2-KO mice were acti-
vated in vitro with TDLN PDCs plus SIINFEKL peptide, with or with-
out 1MT. Proliferation was measured as thymidine incorporation on
successive days during the primary MLR (left panel). On day 3, the
OT-IWT group without 1MT (the only nonproliferating group) was
harvested and tested for anergy in recall MLRs (restimulation with
normal C57BL/6 splenocytes plus peptide antigen), as described
in Experimental Procedures. Recall MLRs were performed with or
without 1MT or IL-2, as shown.
(C) Anergic T cells are rescued by exogenous IL-2, but not by
PMA+ionomycin. OT-IWT T cells were anergized for 3 days by PDCs +
antigen as in the previous panel, then restimulated with either nor-
mal splenocytes + antigen, or with PMA+ionomycin, in the pres-
ence or absence of exogenous IL-2. (*p < .05 by ANOVA versus all
of the groups without IL-2.)by 10× tryptophan might also be consistent with a
(D) Anergy induction in vivo is GCN2 dependent. Labeled OT-IWT
and OT-IGCN2-KO T cells were adoptively transferred into GCN2-KO
hosts, and mice were injected with peptide-pulsed CD11c+ TDLN
DCs. After 5 days, the labeled T cells (CFSE+ CD8+) were recovered
from draining LNs by sorting, and used as responders in recall
MLRs. Stimulator cells were irradiated C57BL/6 splenocytes. MLRs
were performed with or without OVA peptide, and with or without
exogenous IL-2, as shown. The bracket shows statistical compari-
son of OT-IWT versus OT-IGCN2-KO cells by ANOVA, showing that
OT-IGCN2-KO are not rendered anergic.The result may be cell cycle arrest, lineage-specific dif-
ferentiation, metabolic adaptation, or cell death (Niwa
and Walter, 2000) (Anthony et al., 2004; Crosby et al.,
2000; Harding et al., 2000a; Harding et al., 2000b; Har-
ding et al., 2003; Rao et al., 2004; Zhang et al., 2002a;
Zhang et al., 2002b). The biologic importance of this
pathway is suggested by its hypothesized role in set-
tings as diverse as neurodegenerative disorders, Type
2 diabetes, adaptation to oxidative stress, and re-
sponse to viral infection (Forman et al., 2003; Harding
et al., 2003; Ozcan et al., 2004).
In the case of T cells, little is known about the bio-
logic role of the ISR (Beretta, 2004). One effect of ISR
activation is a transient but generalized inhibition of
mRNA translation (translational repression) (Hinne-
busch, 2000). Thus, a key question in the current study
was whether something as apparently “nonspecific” as
translational repression could create antigen-specific
regulation of T cell responses. However, the ISR is not
simply a global repressor; it also actively upregulates a
selective program of downstream response genes. The
ISR pathway enhances (rather than represses) trans-
lation of certain selected genes, because phosphoryla-
tion of eIF2α activates the translation of mRNAs
containing a specific internal ribosomal entry site (Fer-
nandez et al., 2002; Harding et al., 2000a). These GCN2-
responsive mRNAs include potent transcriptional regu-
lators such as GCN4p in yeast (Natarajan et al., 2001)
and ATF4 in animal cells (Harding et al., 2000a; Lu et
al., 2004; Vattem and Wek, 2004). This results in coordi-
nated regulation of a conserved set of downstream
stress-responsive genes (Harding et al., 2003).
We used microarray expression profiling to show that
GCN2 affected a highly restricted set of transcripts in T
cells, most of which were actively upregulated by the
GCN2 pathway. Several of these genes (e.g., CHOP and
Herp) are known to be induced by ISR activation in
other cell types (Harding et al., 2003), while others have
not been previously reported and may be specific to T
cells. Further studies will be required to elucidate the
specific downstream events by which GCN2 triggers
cell-cycle arrest and anergy induction. However, our
microarray data clearly demonstrate that GCN2 can
function as a selective and specific regulatory pathway
in T cells.
Exactly how IDO creates the stress that activates
GCN2 in T cells is not yet known. In the published litera-
ture, the only well-characterized and proven stimulus
for GCN2 activation is a rise in uncharged tRNA, as
would occur if IDO depleted the T cells of tryptophan.
The fact that IDO-mediated suppression was reversed
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onot exclude the alternative possibility that a down-
stream metabolite produced by IDO might interfere with
nthe acylation reaction by which tryptophan is ligated to
its tRNA. Although speculative, such an inhibitory me- f
ttabolite would also cause a rise in uncharged tRNATRP
(by inhibiting the charging reaction), and its effect might v
ebe overcome by 10× tryptophan. With current technol-
ogy, it is not possible to directly measure tryptophan or a
oits metabolites in the local microenvironment of the T
cell, so it is impossible to distinguish between these e
Gtwo speculative scenarios. For this reason, we chose
to focus instead on the downstream response pathway i
Tin the T cell. This approach allowed us to demonstrate
that – whether due to tryptophan depletion or inhibitory l
imetabolites – a key biologic effect of IDO is to activate
the GCN2 pathway. Thus, considered at the level of n
(GCN2 activation, the T cell responds as if it were de-
prived of tryptophan, and this mediates biological re- n
ssponses in the T cell.
One important biological response mediated by G
tGCN2 was the creation of anergy. Anergy is a critical
outcome because it allows the immunoregulatory ef- s
fects of IDO to be extended in time (i.e., beyond the
Einitial physical encounter with the IDO-expressing APC)
At the molecular level, we do not yet know how GCN2
Rparticipates in the induction of anergy, but a number of
A
studies suggest that cell-cycle arrest during early T cell 1
activation may causally contribute to anergy induction p
(Schwartz, 2003). One of the prominent effects of the p
sISR pathway is cell-cycle arrest (Niwa and Walter,
2000), and we speculate that this could be one way in
Mwhich GCN2 contributes to anergy induction.
AWe have previously shown that the anergy created
cby IDO is antigen-specific (Munn et al., 2004a). This
p
raises the question of how a “generalized” pathway e
such as GCN2 could result in antigen-specific regula- r
tion of T cells. No specificity would be conferred by G
atryptophan itself, because GCN2 would respond equ-
dally to any amino acid. However, in our system the par-
tticular amino acid that was actually affected by PDCs
h
was tryptophan (as shown by the fact that adding tryp- M
tophan was sufficient to restore proliferation), and this j
occurred via IDO (as shown by the fact that suppres- t
tsion was lost with IDO-KO PDCs, and was blocked by
t1MT). The expression of IDO itself is under tight bio-
alogic regulation, being expressed only by certain APCs,
G
and induced in these APCs only by specific signals t
(Mellor and Munn, 2004). On the T cell side, we found g
that simply activating GCN2 (e.g., with tryptophan-defi-
ocient medium) was not sufficient to upregulate down-
bstream response genes such as CHOP. Rather, the T
bcells also had to receive an additional activation signal
(
via TCR crosslinking (or via PMA/ionomycin, which d
mimics the TCR signal). This suggests that the IDO/ r
mGCN2 pathway would affect only those T cells that
tsimultaneously encountered their cognate antigen.
gConsistent with this hypothesis, upregulation of CHOP
m
in vivo was found to be restricted to those responder H
cells that became antigen experienced (i.e., were
CD44-positive). Thus, while the GCN2 pathway was not T
in itself specific, it was induced by IDO and acted in T
Mconcert with TCR signaling, which together could con-er contextual and antigen specificity on the regulation
f T cell responses.
Finally, our focus on the role of GCN2 in T cells does
ot mean that T cells are the only possible site of action
or GCN2. GCN2 is widely expressed, and other cell
ypes (including the APC itself) might respond to IDO
ia their own endogenous GCN2 pathway. We and oth-
rs have shown that IDO can mediate potent cell-
utonomous effects (i.e., effects which modify the biol-
gy of the IDO-expressing cell) (Li et al., 2004; Marshall
t al., 2001; van Wissen et al., 2002). Thus, the IDO/
CN2 pathway might influence the biology of the APC
tself, and perhaps even other bystander cells as well.
he current study does not address these more specu-
ative autocrine or paracrine effects, but they may prove
mportant to certain potent but poorly understood phe-
omena such as IDO-mediated bystander suppression
Munn et al., 2004a) and IDO-mediated systemic immu-
osuppression in vivo (Mellor et al., 2003). In the current
tudy, however, the key finding is the identification of
CN2 as a molecular sensor in T cells, which allows
hem to detect and respond to the immunoregulatory
ignal generated by IDO.
xperimental Procedures
eagents
ll reagents were from Sigma (St. Louis, MO) unless noted.
-methyl-D-tryptophan (catalog number 45,248-3, Sigma) was pre-
ared as a 20 mM stock solution in 0.1 N NaOH and adjusted to
H 7.4. L-tryptophan (T0254, Sigma) was prepared as a 25 mM
tock. Both reagents were stored at 4°C and protected from light.
ouse Models
ll animal studies were approved by the institutional animal use
ommittee of the Medical College of Georgia. GCN2-KO mice were
repared with a targeted deletion in the GCN2 locus, removing
xon 12 of the murine EIF2AK4 gene. This encodes for an essential
egion of the GCN2 kinase, abolishing protein phosphorylation by
CN2. The targeted mutation in the EIF2AK4 locus deletes exon 12
nd surrounding intronic sequences. It is identical to the previously
escribed mutation (Harding et al., 2000a), except that the selec-
ion marker used in gene targeting of the W4 embryonic stem cells
ad been removed by Cre-mediated excision at flanking loxP sites.
ice with the targeted mutation were produced by blastocyst in-
ection of the mutant ES cell clone and the mutation was main-
ained in the inbred 129svev (Taconic) strain background. The mu-
ant allele produces little if any detectable mRNA (presumably due
o frame-shifting by splicing of exons 11 to 13, data not shown)
nd is thus referred to here as GCN2-KO. Like previously described
CN2 “knockout” mice (Zhang et al., 2002b), mice homozygous for
his mutant allele were viable, fertile, and appeared overtly indistin-
uishable from wild-type mice.
TCR-transgenic OT-I mice, recognizing the SIINFEKL peptide of
valbumin presented by H2Kb (Hogquist et al., 1994), C57BL/6
ackground, were purchase from Jackson Laboratories (Bar Har-
or, ME). The C57BL/6 and 129 backgrounds are MHC-matched
b-haplotype); there was no discernable effect of minor antigenic
ifferences between the B6 and 129 backgrounds, and OT-I cells
esponded identically to APCs from B6 or 129 backgrounds. OT-I
ice were backcrossed three generations with GCN2-KO mice and
hen self mated. BM3 mice (TCR-transgenic CD8+, CBA back-
round) have been previously described (Tarazona et al., 1996). A1
ice (TCR-transgenic CD4+, CBA background, recognizing a male
Y peptide on H2Ek) have been described (Zelenika et al., 1998).
umor Models
umors were initiated using 1 × 106 B78H1·GM-CSF cells (an
HC-deficient subline of B16 melanoma transfected with GM-CSF
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641([Huang et al., 1994]; gift of S. Antonia, Moffitt Cancer Center,
Tampa FL), implanted subcutaneously in the thigh as previously
described (Munn et al., 2004a), using the following hosts: C57BL/6
mice; IDO-KO mice bred on the F1(B6×CBA) background (Mellor et
al., 2003); or wild-type F1(CBA×B6) mice.
Flow Cytometry and Cell Sorting
TDLN PDCs were isolated as described (Munn et al., 2004a), using
high-speed cell sorting for CD11c versus B220. Intracellular stain-
ing for CHOP was performed as described for intracellular IDO
(Munn et al., 2004b), using monoclonal antibody sc-7351 (Santa
Cruz Biotechnology, Santa Cruz, CA).
T Cell Proliferation
Responder CD8+ T cells were prepared from spleens by sorting for
CD8 cells (clone 53.6.7) using a CD11cNEGB220NEG gate to exclude
CD8α+ DCs. Sorted PDCs were mixed with 1 × 105 responder T
cells at a DC:T cell ratio of 1:40. Stimulator DCs were not irradiated.
MLRs were performed as described (Munn et al., 2004a), using
V-bottom culture wells to ensure cell-cell contact. Some experi-
ments received 50 ng/ml PMA + 500 ng/ml ionomycin; or 1 g/ml
anti-CD3 antibody. OT-I cells received 100 nM SIINFEKL peptide in
the MLRs. Where indicated, groups received 200 M 1MT (D-iso-
mer) or 250 M L-tryptophan.
Gene Expression Microarrays
Splenic T cells (wild-type 129 or GCN2-KO) were nylon wool en-
riched and activated with PMA+ionomycin for 40 hr, then half of
each group received tryptophanol (0.25 mM) or buffer control for
an additional 3 hr. Total RNA was purified by RNEasy columns (Qia-
gen, Valencia, CA), labeled by the MCG Microarray Core Facility
using standard Affymetrix protocols, and hybridized to mouse ge-
nome arrays (GeneChip 430A2.0, Affymetrix, Santa Clara, CA). The
Affymetrix system used in these experiments generates a signal
normalized to internal standards, which allows expression levels to
be compared across chips. Two identical experiments were per-
formed, for a total of eight array hybridizations.
Adoptive Transfer Studies
Recipient mice were prepared by intravenous injection of 5 × 106
OT-I cells (either OT-IGCN2-KO or OT-IWT, nylon-wool enriched), la-
beled with 5 M carboxyfluorescein diacetate succinimidyl ester
(CFSE, Molecular Probes, Eugene, OR) for 10 min at 37°C. Host
mice were GCN2-KO littermates (on the same GCN2-KO B6×129
background as the OT-IGCN2-KO mice but without the OT-I
transgene), or wild-type C57BL/6. As in our previous publication
(Munn et al., 2004a), the entire CD11c+ DC fraction (unsorted
CD11c+B220+ cells) was used for injection because this gave better
viability of the PDC population during peptide loading, washing,
and injection. Since IDO-mediated suppression is dominant, the
unfractionated CD11c+ preparation was still potently suppressive.
CD11c+ DCs were incubated with 100 nM SIINFEKL peptide for 30
min at 37°C, washed, and 5 x 104 DCs injected subcutaneously into
the anteriomedial thigh of each recipient. Where indicated, mice
received 1-methyl-D-tryptophan (NSC 721782, National Cancer In-
stitute, Rockville, MD) via implantable copolymer pellets (Munn et
al., 1998), or control pellets without 1MT. After 3 days, the inguinal
LNs were harvested and analyzed by FACS for CFSE versus CD8
versus other markers (1B11, CD44, or intracellular CHOP). For in
vivo anergy experiments, CFSE-labeled CD8+ T cells were sorted
from the LNs on day 5, and used as responder cells in recall MLR
assays (below).
Anergy Induction and Recall MLRs
For in vitro anergy induction, CD8+ OT-IWT T cells were incubated
for 72 hr with IDO+ TDLN PDCs plus SIINFEKL peptide (primary
MLRs). Cells were harvested, washed, and resuspended at 2× the
original seeding density, in 50% fresh medium plus 50% original
conditioned medium. Recall MLRs were stimulated by C57BL/6
spleen cells plus SIINFEKL peptide, or by PMA + ionomycin, and
replicate groups received recombinant mouse IL-2 as described
(Munn et al., 2004a).Quantitative Real-Time RT-PCR for CHOP
RNA analysis was performed on the LightCycler real-time quantita-
tive PCR system (Roche Diagnostics, Indianapolis, IN), using SYBR
Green RNA Amplification Kit (Roche), and quantitated against a
standard curve prepared from RAW cells treated with thapsagargin
(Harding et al., 2000a). Primers for mouse CHOP were 5#-TCC
CTGCCTTTCACCTTG-3# (sense) and 5#-GCCCTGGCTCCTCTG
TCA-3# (antisense). Primers for mouse γ-actin were 5#-GATGACG
CAGATAATGTTT-# (sense) and 5#-TCTCCTTTATGTCACGAAC-3#
(antisense). Both primer pairs gave a single band, and the method
was linear over a 3-log range.
Western Blots and Immunohistochemistry
Immunohistochemistry was performed as previously described
(Munn et al., 2004a). Western blot for CHOP was performed using
anti-gadd153/CHOP antibody (1:100 dilution) with PVDF mem-
branes.
Statistical Analysis
Groups within a single experiment were compared by ANOVA. Ex-
periments were repeated at least three times unless otherwise
stated.
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